Dendritic cell immunotherapy: mapping the way

被引:778
作者
Figdor, CG
de Vries, IJM
Lesterhuis, WJ
Melief, CJM
机构
[1] Univ Med Ctr Nijmegen, Nijmegen Ctr Mol Life Sci, Dept Tumor Immunol, NL-6500 HB Nijmegen, Netherlands
[2] Univ Med Ctr Nijmegen, Nijmegen Ctr Mol Life Sci, Dept Med Oncol, NL-6500 HB Nijmegen, Netherlands
[3] Univ Med Ctr Leiden, Dept Immunohematol & Blood Transfus, NL-2300 RA Leiden, Netherlands
关键词
D O I
10.1038/nm1039
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dendritic cells (DCs) are the professional antigen-presenting cells of the immune system, with the potential to either stimulate or inhibit immune responses. Exploiting the immune-regulatory capacities of dendritic cells holds great promise for the treatment of cancer, autoimmune diseases and the prevention of transplant rejection. Although early clinical trials indicate that DC vaccines can induce immune responses in some cancer patients, careful study design and use of standardized clinical and immunological criteria are needed.
引用
收藏
页码:475 / 480
页数:6
相关论文
共 50 条
  • [1] Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases
    Adorini, L
    Penna, G
    Giarratana, N
    Uskokovic, M
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 88 (02) : 227 - 233
  • [2] Banchereau J, 2001, CANCER RES, V61, P6451
  • [3] Dendritic cells as vectors for therapy
    Banchereau, J
    Schuler-Thurner, B
    Palucka, AK
    Schuler, G
    [J]. CELL, 2001, 106 (03) : 271 - 274
  • [4] BERNHARD H, 1995, CANCER RES, V55, P1099
  • [5] Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance
    Bonifaz, L
    Bonnyay, D
    Mahnke, K
    Rivera, M
    Nussenzweig, MC
    Steinman, RM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (12) : 1627 - 1638
  • [6] Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: Dependency on antigen dose and differential toll-like receptor ligation
    Boonstra, A
    Asselin-Paturel, C
    Gilliet, M
    Crain, C
    Trinchieri, G
    Liu, YJ
    O'Garra, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (01) : 101 - 109
  • [7] Bostanci A, 2002, SCIENCE, V298, P1531
  • [8] Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes
    Bousso, P
    Robey, E
    [J]. NATURE IMMUNOLOGY, 2003, 4 (06) : 579 - 585
  • [9] Dendritic cells: a journey from laboratory to clinic
    Cerundolo, V
    Hermans, IF
    Salio, M
    [J]. NATURE IMMUNOLOGY, 2004, 5 (01) : 7 - 10
  • [10] de Vries IJM, 2003, CANCER RES, V63, P12